Marrone Bio Innovations, Inc. (NASDAQ:MBII) was downgraded by stock analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.

MBII has been the topic of a number of other reports. Zacks Investment Research downgraded shares of Marrone Bio Innovations from a “hold” rating to a “sell” rating in a report on Wednesday, May 17th. HC Wainwright set a $4.00 target price on shares of Marrone Bio Innovations and gave the stock a “buy” rating in a report on Tuesday, August 15th. Finally, Piper Jaffray Companies set a $1.00 target price on shares of Marrone Bio Innovations and gave the stock a “hold” rating in a report on Saturday, July 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $2.50.

Shares of Marrone Bio Innovations (NASDAQ MBII) traded down 4.20% on Friday, reaching $1.14. 107,313 shares of the company’s stock traded hands. Marrone Bio Innovations has a 52 week low of $0.85 and a 52 week high of $2.79. The firm’s market capitalization is $35.74 million. The company has a 50 day moving average price of $1.13 and a 200 day moving average price of $1.47.

Marrone Bio Innovations (NASDAQ:MBII) last released its quarterly earnings results on Monday, August 14th. The basic materials company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by $0.04. The business had revenue of $6.48 million for the quarter, compared to the consensus estimate of $6.62 million. On average, equities research analysts predict that Marrone Bio Innovations will post ($1.01) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/02/marrone-bio-innovations-inc-mbii-lowered-to-strong-sell-at-valuengine.html.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Receive News & Stock Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related stocks with our FREE daily email newsletter.